Arcutis Biotherapeutics Inc (ARQT) — Cash Flow Reinvestment Rate
Latest as of June 2026:
1.20x
Arcutis Biotherapeutics Inc (ARQT) has a Cash Flow Reinvestment Rate of 1.20x as of June 2026, reinvesting $15.22 Million (capex $158.00K plus investments $-15.07 Million) from operating cash flow of $12.64 Million. See ARQT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
1.20x
(Capex + Investments) / Operating CF
Total Reinvested
$15.22 Million
Capex + Investments
Operating Cash Flow
$12.64 Million
USD
Capital Expenditures
$158.00K
USD
Annual Cash Flow Reinvestment Rate for Arcutis Biotherapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Arcutis Biotherapeutics Inc. See Arcutis Biotherapeutics Inc (ARQT) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow